Short Bowel Syndrome Is Not a Contraindication for Kidney Transplantation
Authors:
- Tugba Tastemel OzturkTOTugba Tastemel Ozturk
- Bora GulhanBGBora Gulhan
- Ersin GumusEGErsin Gumus
- Hayriye Hizarcioglu‐GulsenHHHayriye Hizarcioglu‐Gulsen
- Eda Didem Kurt‐SukurEKEda Didem Kurt‐Sukur
- Ali Cansu BozaciABAli Cansu Bozaci
- Fazil Tuncay AkiFAFazil Tuncay Aki
- Ali DuzovaADAli Duzova
- Rezan TopalogluRTRezan Topaloglu
- Fatih OzaltinFOFatih Ozaltin
- 11 November 2024
- journal article
- research article
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (8) , e14889
Abstract
Background: Short bowel syndrome (SBS) is a malabsorptive condition that develops as a result of massive resection of the small intestine and causes morbidities such as chronic diarrhea, dehydration attacks, parenteral nutrition (PN) dependence, and recurrent infections. Kidney transplantation in this patient group may be complicated by aforementioned morbidities, as well as the absorption problems of immunosuppressive drugs.Methods: We report the first pediatric patient (18‐month‐old male) with SBS secondary to volvulus who underwent a successful living related kidney transplantation with a primary diagnosis of autosomal recessive polycystic kidney disease and had a successful 4‐year follow‐up without intestinal transplantation.Results: Tacrolimus, mycophenolate mofetil (MMF), and prednisolone were administered for maintenance of immunosuppression after transplantation. The patient reached therapeutic trough levels of tacrolimus with usual doses. The 4‐year renal survival was excellent without a clinical evidence of rejection, despite long‐term necessity of PN and intravenous fluids.Conclusions: Kidney transplantation should not be avoided in patients with SBS solely because of concerns about the effectiveness of immunosuppressive therapy. Prednisolone, tacrolimus, and MMF combination was effective in our case, and these drugs can be considered as first‐line agents in these patients.Keywords
This publication has 10 references indexed in Scilit:
- Nutrition and Intestinal Rehabilitation of Children With Short Bowel SyndromeJournal of Pediatric Gastroenterology and Nutrition, 2023
- An Overview of Short-Bowel Syndrome in Pediatric Patients: Focus on Clinical Management and Prevention of ComplicationsNutrients, 2023
- Short Bowel Syndrome and Kidney Transplantation: Challenges, Outcomes, and the Use of TeduglutideCase Reports in Transplantation, 2020
- Long-Term Outcomes of Intestinal and Multivisceral Transplantation at a Single Center in ArgentinaTransplantation Proceedings, 2016
- Short bowel syndrome in children: Surgical and medical perspectivesSeminars in Pediatric Surgery, 2014
- Tarm- og flerorgantransplantasjon ved kronisk tarmsviktTidsskrift for Den norske legeforening, 2012
- Comparison of Short Bowel Syndrome Acquired Early in Life and During AdolescenceTransplantation, 2008
- Immunosuppression in infants with short bowel syndrome undergoing isolated liver transplantationPediatric Transplantation, 2006
- Pharmacokinetic Principles of Immunosuppressive DrugsAmerican Journal of Transplantation, 2005
- Pharmacokinetics of tacrolimus and cyclosporine in short-bowel syndromeLiver Transplantation and Surgery, 1998